Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

Affiliations

• ¹ Associate Professor, Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
• ² Senior Vice President, Applied and Clinical Business Segments, MOBILion Systems, Chadds Ford, PA, United States.
• ³ Associate Director, Center for Psychedelic and Consciousness Research, Associate Professor, Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
• ⁴ Director, Toxicological Services, NMS Labs, Horsham, PA, United States.
• ⁵ Vice President, In Vitro Diagnostic Regulatory Affairs, MCRA, LLC, Washington, DC, United States.
• ⁶ Medicinal Chemist, Usona Institute, Fitchburg, WI, United States.
• ⁷ Chief Medical Officer, Beckley Psytech Ltd, San Francisco, CA, United States.